|
SLC39A6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.11859999987851E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.41289999699978E-08 |
| Normal-vs-Stage2 |
2.066000E-02 |
| Normal-vs-Stage3 |
3.296500E-03 |
| Normal-vs-Stage4 |
3.280400E-01 |
| Stage1-vs-Stage2 |
4.344600E-01 |
| Stage1-vs-Stage3 |
2.364000E-01 |
| Stage1-vs-Stage4 |
5.070600E-01 |
| Stage2-vs-Stage3 |
8.559600E-01 |
| Stage2-vs-Stage4 |
7.596200E-01 |
| Stage3-vs-Stage4 |
8.510000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.74099999972199E-07 |
| Normal-vs-AfricanAmerican |
5.987000E-04 |
| Normal-vs-Asian |
1.677620E-03 |
| Caucasian-vs-AfricanAmerican |
6.766000E-01 |
| Caucasian-vs-Asian |
5.415800E-01 |
| AfricanAmerican-vs-Asian |
4.224000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.31559993402186E-10 |
| Normal-vs-Female |
6.352600E-01 |
| Male-vs-Female |
2.1325000000294E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.757300E-03 |
| Normal-vs-Extreme_Weight |
2.80580003675368E-10 |
| Normal-vs-Obese |
7.56800000000224E-05 |
| Normal-vs-Extreme_Obese |
3.199600E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.778400E-02 |
| Normal_Weight-vs-Obese |
9.895400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.023600E-01 |
| Extreme_Weight-vs-Obese |
2.098100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.804400E-01 |
| Obese-vs-Extreme_Obese |
3.898800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.859000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.11459999999164E-05 |
| Normal-vs-Age(61-80Yrs) |
5.93840000506773E-08 |
| Normal-vs-Age(81-100Yrs) |
1.61035999999282E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.839030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.673500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.690400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.704000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.046970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.231200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.35339978008165E-10 |
| Normal-VS-Type2 PRCC |
1.86293999999698E-05 |
| Normal-VS-KIRP CIMP |
1.866410E-01 |
| Normal-VS-Unclassified PRCC |
2.708000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.213760E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.275650E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.646300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.442200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.831000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.866300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.9457000000056E-06 |
| Normal-vs-N1 |
6.137600E-02 |
| Normal-vs-N2 |
6.187400E-01 |
| N0-vs-N1 |
7.987700E-02 |
| N0-vs-N2 |
2.817000E-01 |
| N1-vs-N2 |
4.245000E-01 |
|
|
